IRVINE, Calif., May 27, 2015 /PRNewswire/ -- Syneron
Medical Ltd. (NASDAQ: ELOS), a global leader in the aesthetic
medical device marketplace, introduces UltraShape®,
an innovative and fast way to lose stubborn belly fat.
TV Star And Mother Of Four Turns To
UltraShape To Get Rid Of Stubborn
Fat
UltraShape's newest devotee, Larsa Pippen, Real Housewives of
Miami Alumni, wife of six-time world champion NBA star
Scottie Pippen, and fitness
enthusiast, talked about her UltraShape experience during a
May 6 press conference in
New York City. Larsa said of the
treatment, "UltraShape gives me more confidence. I eat well and
exercise regularly, but as a mom of four, there are certain areas
that are resistant to all my efforts. With UltraShape, the inches
are disappearing; I lost 1.5 inches and I love my results so much
that even my mom and my friends are doing it, too." Even those who
are fully committed to living a healthy lifestyle and who maintain
meticulous beauty routines still see results with UltraShape.
Pippen further detailed, "UltraShape delivers fast results without
pain or downtime."
Fast Results
As the perfect complement to a regular diet and exercise
regimen, UltraShape targets extra abdominal fat that just won't
budge, despite a healthy lifestyle. An easy, painless, and faster
alternative to traditional body shaping treatments, UltraShape can
help consumers drop up to two sizes in just three 45-minute
sessions.* Treatments take less than an hour and patients can go
right back to their normal activities, making it an ideal lunch
hour treatment. First results may be visible as early as two weeks
post treatment. Finally, there's a way to achieve a flatter
stomach, without the agony of countless sit-ups and crunches.
As the first and only FDA-approved non-invasive body contouring
system that uses focused, pulsed ultrasound energy to target and
instantly destroy stubborn fat, UltraShape offers measurable fat
reduction to the abdominal area without the risks and downtime
associated with other fat reduction procedures. "UltraShape is the
fastest non-invasive fat reduction technology; nothing non-invasive
works faster," states Leslie
Baumann, MD. "UltraShape's patented technology delivers
ultrasound energy with extraordinary accuracy, allowing us to
target and destroy fat cells immediately. Unlike traditional
ultrasound technology, UltraShape distributes energy in pulses
rather than in a single continuous delivery, which can be painful.
The result is a quick, safe and comfortable treatment experience
without the lumps, bumps or soreness associated with other
non-invasive fat reduction treatments."
"UltraShape uses ultrasound technology that was perfected in 10
years of research and developed by world leading scientists and
doctors to non-invasively destruct fat without any damage to
surrounding tissue," states Shimon
Eckhouse, Ph.D., Chairman of the Board of Directors
for Syneron Candela.
Research conducted by Syneron Candela found that 60 percent of
women are dissatisfied with their abdominal area, and 52 percent
would consider having a non-invasive procedure.[1] "Our goal with
UltraShape is to revolutionize the way men and women achieve a
flatter abdominal region by offering technologically advanced,
non-invasive and comfortable options to reduce stubborn abdominal
fat," says Ilan Nacasch, Chief Brand
Officer at Syneron Candela.
To learn more about UltraShape, visit: www.ultrashape.com
About Syneron Candela
Syneron Candela is a leading global aesthetic device company
with a comprehensive product portfolio and a global distribution
footprint. The Company's technology enables physicians to
provide advanced solutions for a broad range of medical-aesthetic
applications including body contouring, hair removal, wrinkle
reduction, tattoo removal, improving the skin's appearance through
the treatment of superficial benign vascular and pigmented lesions,
and the treatment of acne, leg veins and cellulite. The Company
sells its products under three distinct brands, Syneron, Candela
and CoolTouch, and has a wide portfolio of trusted, leading
products including UltraShape, VelaShape, GentleLase, VBeam
Perfecta, PicoWay, Profound and elos Plus.
Founded in 2000, the corporate, R&D, and manufacturing
headquarters for Syneron Candela are located in Israel. Syneron Candela also has R&D and
manufacturing operations in the U.S. The company markets,
services and supports its products in 86 countries. It has
offices in North America,
France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan,
and Hong Kong and distributors
worldwide.
For additional information, please visit
http://www.syneron-candela.com.
SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS
This news release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995
that involve risks and uncertainties. Such forward-looking
statements include the expectations, plans and prospects for the
Company, including product efficacy, market acceptance of new
products, and projected revenues, margins, earnings and market
shares. The statements made by the Company are based upon
management's current expectations and are subject to certain risks
and uncertainties that could cause actual results to differ
materially from those described in the forward-looking statements.
These risks and uncertainties include the risk factors and
other cautionary statements described in the Company's filings with
the SEC, including those described in the Company's most recent
Annual Report on Form 20-F, and in the filings that Syneron Medical
makes with the SEC, and other factors beyond the Company's control.
If one or more of these factors materialize, or if any underlying
assumptions prove incorrect, Syneron Medical Ltd.'s actual results,
performance or achievements may vary materially from those
expressed or implied by these forward-looking statements.
These forward-looking statements should not be relied upon as
representing Syneron Medical Ltd.'s views as of any date after the
date of this document. The Company does not intend to update these
statements and undertakes no duty to any person to provide any such
update under any circumstance.
Syneron Medical – Public Relations
KELZ PR,
646-450-5359
Melissa Ben-Yoseph,
Melissa@kelzpr.com
Patty Mathews,
pattymathews@kelzpr.com
Twitter
Facebook
YouTube
*Individual results may vary.
[1] Syneron data on file
Photo:
http://photos.prnewswire.com/prnh/20150526/218409
Photo: http://photos.prnewswire.com/prnh/20150526/218410
Logo - http://photos.prnewswire.com/prnh/20120528/535447
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/syneron-candela-unveils-larsa-pippen-as-newest-ultrashape-brand-champion-300089371.html
SOURCE Syneron